DERIVE DE L'ANDROSTENONE

European patent · EP0719278 · Deleted

Register entry

Publication number
EP0719278
Application number
EP94929828
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 16, 1994
Published
Jul 3, 1996
Granted
Jan 14, 1998
Deleted
Sep 15, 2014
Reason
Maximum term reached
IPC classes
C07J 73/00 (2006.01)
C07J 41/00 (2006.01)
A61K 31/58 (2006.01)
C07C 235/82 (2006.01)
Priority
US 123280 17.09.1993
PCT application
PCT/US1994/010530 16.09.1994
PCT publication
WO1995/007927 23.03.1995
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Dutasterid

C00719278/01 · Medicine · Granted · Protection from Sep 16, 2014 to Jan 12, 2018

Authorisation 56106 (Swissmedic, Jan 13, 2003)

Deleted, Maximum term reached

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 22, 2014

    Maximum term reached

    Published in Swissreg on 22.09.2014

  2. Aug 16, 2014

    Transferred

    Owner
    GlaxoSmithKline LLC, Suite 400, 2711 Centreville Road, Wilmington, Delaware 19808, USA → Glaxo Group Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom

    Published in Swissreg on 16.08.2014

  3. Aug 16, 2014

    Licensee entered

    License holder
    SmithKline Beecham (Cork) Limited, Currabinny, Carrigaline, County Cork, Ireland

    Published in Swissreg on 16.08.2014

  4. Aug 16, 2014

    Licensee entered

    License holder
    SmithKline Beecham (Cork) Limited, Currabinny, Carrigaline, County Cork, Ireland → SmithKline Beecham (Cork) Limited, Currabinny, Carrigaline, County Cork, Ireland, GlaxoSmithKline AG, Talstrasse 3-5, 3053 Münchenbuchsee

    Published in Swissreg on 16.08.2014

  5. Aug 15, 2014

    Address changed

    Owner
    SmithKline Beecham Corporation, One Franklin Plaza, 200 North 16th Street, Philadelphia, PA 19102, USA → GlaxoSmithKline LLC, Suite 400, 2711 Centreville Road, Wilmington, Delaware 19808, USA

    Published in Swissreg on 15.08.2014

  6. Dec 28, 2007

    Agent entered

    Representative
    Braun & Partner, Patent-, Marken-, Rechtsanwälte, Reussstrasse 22, CH-4054 Basel → Braunpat Braun Eder AG, Reussstrasse 22, 4054 Basel

    Published in +pat+ No 24 in 2007

  7. Apr 15, 2003

    Address changed

    Owner
    GLAXO WELLCOME INC., 5 Moore Drive,, Box 13398, Research Triangle Park,, North Carolina 27709, USA → SmithKline Beecham Corporation, One Franklin Plaza, 200 North 16th Street, Philadelphia, PA 19102, USA

    Published in +pat+ No 7 in 2003

  8. Jan 30, 1998

    Agent entered

    Representative
    Braun & Partner, Patent-, Marken-, Rechtsanwälte, Reussstrasse 22, CH-4054 Basel

    Published in PIDTJ No 2 in 1998

1 earlier entry
  1. Jan 15, 1998

    Granted

    Published in PIDTJ No 1 in 1998

Parties

Holder

Glaxo Group Limited

980 Great West Road, Brentford, Middlesex TW8 9GS, GB

Agent

BRAUNPAT AG

Braunpat Braun Eder AG

Reussstrasse 22, 4054 Basel

Inventor

BATCHELOR, Kenneth W.

Research Triangle Park, NC 27709, US

FRYE, Stephen V.

Research Triangle Park, NC 27709, US

Licensee

SmithKline Beecham (Cork) Limited

Currabinny, Carrigaline, County Cork, IE

GlaxoSmithKline AG

Talstrasse 3-5, 3053 Münchenbuchsee

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.